Home / INDP : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does INDP make money? Does INDP have pricing power? What's the Earnings Whisper? Will INDP profit more as the business scales? What is INDP's management track record? Is INDP's current price justified?

Indaptus Therapeutics, Inc.

$2.77 +$0.03 (+1.09%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$2.56

Day Range

$2.46$2.94

Year Range

$0.92$8.57

Market Cap

313.68M

AVG Volume

Trailing/Forward PE

-0.4/-

PEG ratio

0.01

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Net Income (USD) · TTM

INDP Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-15.42M
26 Q1	-18.86M
25 Q4	-20.85M
25 Q3	-16.87M
25 Q2	-16.96M
25 Q1	-15.75M
24 Q4	-15.02M
24 Q3	-14.89M
24 Q2	-15.75M
24 Q1	-14.98M

Operating Income (USD) · TTM

INDP Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-14.77M
26 Q1	-17.42M
25 Q4	-19.83M
25 Q3	-15.85M
25 Q2	-16.34M
25 Q1	-16M
24 Q4	-15.37M
24 Q3	-15.37M
24 Q2	-16.48M
24 Q1	-15.87M

EBITDA (USD) · TTM

INDP EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-15.45M
26 Q1	-18.86M
25 Q4	-20.85M
25 Q3	-16.87M
25 Q2	-16.96M
25 Q1	-15.75M
24 Q4	-15.02M
24 Q3	-14.89M
24 Q2	-15.75M
24 Q1	-14.98M

Cash Flows (USD) · TTM

INDP Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-15.18M
26 Q1	-17.27M
25 Q4	-15.31M
25 Q3	-15.52M
25 Q2	-14.97M
25 Q1	-13.43M
24 Q4	-12.32M
24 Q3	-11.53M
24 Q2	-12.75M
24 Q1	-12.38M

EPS (USD) · TTM

INDP EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-6.97
26 Q1	-16.05
25 Q4	-24.82
25 Q3	-21.52
25 Q2	-18.86
25 Q1	-10.23
24 Q4	-1.68
24 Q3	-1.72
24 Q2	-1.87
24 Q1	-1.79

Expenses (USD) · TTM

INDP Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	14.77M
26 Q1	17.42M
25 Q4	19.83M
25 Q3	15.85M
25 Q2	16.34M
25 Q1	16M
24 Q4	15.37M
24 Q3	15.37M
24 Q2	16.48M
24 Q1	15.87M

Shares Outstanding · TTM

INDP Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-948.71K
26 Q1	-1.19M
25 Q4	-1.21M
25 Q3	-725.78K
25 Q2	-1.17M
25 Q1	-1.77M
24 Q4	-2.31M
24 Q3	-2.75M
24 Q2	-3.07M
24 Q1	-3.01M

Employee Count

INDP Employee Count by quarter
Period	Employee Count
2025	5
2024	7
2023	7
2022	6
2021	5

Free Cash Flow Yield

INDP Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-4.72%
Sep 26	-10.72%
Aug 26	-11.47%
Aug 26	-10.13%
Aug 26	-12.22%
Aug 26	-133.6%
Jul 26	-122.21%
Jul 26	-60.4%
Jul 26	-62.31%
Jul 26	-59.94%
Jul 26	-52.03%
Jun 26	-46.23%
Jun 26	-40.42%
Jun 26	-44.04%
Jun 26	-43.07%
May 26	-89.57%
May 26	-129.22%
May 26	-99.15%
May 26	-375.76%
May 26	-330.1%
Apr 26	-214.07%
Apr 26	-204.76%
Apr 26	-334.8%
Apr 26	-441.51%
Mar 26	-396.87%
Mar 26	-415.54%
Mar 26	-879.2%
Mar 26	-841.18%
Feb 26	-755.43%
Feb 26	-770.39%
Feb 26	-884.19%
Feb 26	-864.54%
Jan 26	-707.35%
Jan 26	-574.24%
Jan 26	-453.7%
Jan 26	-497.18%
Jan 26	-567.95%
Dec 25	-610.27%
Dec 25	-766.59%
Dec 25	-637.78%
Dec 25	-622.47%
Nov 25	-697.84%
Nov 25	-841.18%
Nov 25	-619.99%
Nov 25	-1025.41%
Oct 25	-808.86%
Oct 25	-717.5%
Oct 25	-703.93%
Oct 25	-664.42%
Oct 25	-796.49%
Sep 25	-746.29%
Sep 25	-936.88%
Sep 25	-1009.51%
Sep 25	-789.25%
Aug 25	-400.7%
Aug 25	-354.36%
Aug 25	-365.81%
Aug 25	-372%
Aug 25	-365.38%
Jul 25	-268.88%
Jul 25	-229.94%
Jul 25	-222.27%
Jul 25	-240.51%
Jun 25	-229.15%
Jun 25	-352.81%
Jun 25	-293.43%
Jun 25	-277.55%
May 25	-281.95%
May 25	-258.21%
May 25	-212.19%
May 25	-11.74%
May 25	-10.23%
Apr 25	-9.99%
Apr 25	-9.8%
Apr 25	-9.8%
Apr 25	-10.19%
Mar 25	-7.97%
Mar 25	-6.53%
Mar 25	-5.84%
Mar 25	-5.25%
Feb 25	-5.16%
Feb 25	-5.41%
Feb 25	-5.42%
Feb 25	-5.44%
Jan 25	-4.76%
Jan 25	-4.56%
Jan 25	-5.14%
Jan 25	-4.56%
Jan 25	-4.92%
Dec 24	-5.18%
Dec 24	-4.62%
Dec 24	-4.33%
Dec 24	-4.16%
Nov 24	-4.24%
Nov 24	-5.33%
Nov 24	-4.8%
Nov 24	-4.48%
Nov 24	-4.56%
Oct 24	-3.95%
Oct 24	-3.53%

Price/Operating Cashflow

INDP Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Nov 21	826.31
Nov 21	830.72
Oct 21	789.9
Oct 21	791.01
Oct 21	860.51
Oct 21	847.27
Oct 21	859.41
Sep 21	973.04
Sep 21	1112.04
Sep 21	841.75
Sep 21	974.14
Aug 21	1092.18
Aug 21	1016.06
Aug 21	469.55
Aug 21	547.9
Jul 21	641.02
Jul 21	774.44
Jul 21	765.36
Jul 21	723.91
Jul 21	792.61
Jun 21	619.14
Jun 21	860.21
Jun 21	672.91
Jun 21	657.3
May 21	653.83
May 21	660.77
May 21	596.6
May 21	613.94
Apr 21	702.39
Apr 21	750.95
Apr 21	664.24
Apr 21	738.81
Apr 21	785.64
Mar 21	731.87
Mar 21	809.92
Mar 21	796.04
Mar 21	688.52

Price to Book

INDP Price to Book by quarter
Period	Price to Book
Sep 26	28.29
Sep 26	12.46
Aug 26	11.64
Aug 26	13.17
Aug 26	10.93
Aug 26	10.36
Jul 26	11.33
Jul 26	22.92
Jul 26	22.21
Jul 26	23.09
Jul 26	26.6
Jun 26	29.94
Jun 26	34.24
Jun 26	31.43
Jun 26	32.14
May 26	15.45
May 26	10.71
May 26	13.96
May 26	1.29
May 26	1.47
Apr 26	2.27
Apr 26	2.37
Apr 26	1.45
Apr 26	1.1
Mar 26	1.22
Mar 26	1.17
Mar 26	0.38
Mar 26	0.4
Feb 26	0.45
Feb 26	0.44
Feb 26	0.38
Feb 26	0.39
Jan 26	0.48
Jan 26	0.59
Jan 26	0.74
Jan 26	0.68
Jan 26	0.59
Dec 25	0.55
Dec 25	0.44
Dec 25	0.53
Dec 25	0.54
Nov 25	0.48
Nov 25	0.4
Nov 25	0.54
Aug 25	1.29
Aug 25	1.31
Jul 25	1.78
Jul 25	2.09
Jul 25	2.16
Jul 25	2
Jun 25	2.09
Jun 25	1.36
Jun 25	1.64
Jun 25	1.73
May 25	1.7
May 25	1.86
May 25	2.26
May 25	26.61
May 25	30.55
Apr 25	31.28
Apr 25	31.87
Apr 25	31.87
Apr 25	30.66
Mar 25	39.18
Mar 25	47.84
Mar 25	53.46
Mar 25	36.59
Feb 25	37.21
Feb 25	35.49
Feb 25	35.44
Feb 25	35.3
Jan 25	40.37
Jan 25	42.14
Jan 25	37.36
Jan 25	42.14
Jan 25	39.03
Dec 24	37.09
Dec 24	41.6
Dec 24	44.36
Dec 24	46.13
Nov 24	45.24
Nov 24	38.8
Nov 24	43.06
Nov 24	46.17
Nov 24	45.39
Oct 24	52.38
Oct 24	58.58
Oct 24	49.27
Oct 24	45
Sep 24	50.44
Sep 24	54.7
Sep 24	58.58
Sep 24	55.48
Aug 24	64.01
Aug 24	63.24
Aug 24	64.01
Aug 24	42.93
Aug 24	47.73
Jul 24	52.02
Jul 24	53.79

No video analysis for this stock yet. Request one from our team.

News: INDP

globenewswire.com · 13 Aug 2026

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a biotechnology company dedicated to immunotherapy research, today announced financial results for the second quarter and six months ended June 30, 2026, and provided a corporate update.

globenewswire.com · 17 Jun 2026

Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders

STAMFORD, Conn., June 17, 2026 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Indaptus Therapeutics, Inc. (Nasdaq: INDP) who held their shares prior to December 22, 2025.

AI Analysis

Indaptus Therapeutics, Inc.

Video analysis: INDP

News: INDP

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders

Similar companies